Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality

Table 2

Questionnaire scores and internal consistency.

	Mean/median (range)	SD	Cronbach’s alpha	Correlation item/total	Pathological
MAX-PC patients	18.57/17 (11–41)	6.43	0.87	0.3 (0.26–0.34)	20/184 (10.9%)
PSA anxiety	7.93/7 (3–17)	2.67	0.83	0.45 (0.3–0.52)	52/184 (28.3%)
Fear of recurrence	4.90/ 5 (0–11)	2.75	0.82	0.43 (0.36–0.5)	18/184 (9.8%)
General anxiety	5.1/5 (2–15)	2.01	0.8	0.4 (0.33–0.46)	19/184 (10.32%)
HADS patient
HADS-A (anxiety)	5.72/5 (1–16)	3.57	0.9	0.48 (0.42–0.54)	26/184 (14.1%)
HADS-D (depression)	4.96/5 (1–12)	2.04	0.71	0.26 (0.20–0.32)	13/184 (7.06%)
HADS spouse
HADS-A (anxiety)	4.63 /4 (0–13)	3.87	0.86	0.48 (0.41–0.56)	22/137 (16.05%)
HADS-D (depression)	3.7/4 (0–13)	3.3	0.79	0.35 (0.28–0.44)	12/137 (8.8%)
PHQ-9 patient
PHQ-9 ()	4.74/6 (0–13)	3.15	0.89	0.601 (0.18–1)	17/184 (9.2%)
Major depressive s.	1/184 (0.5%)
Other depressive s.	5 (2.7%)
Depressive s. +	11 (6%)
Depressive s. −	167 (90.8%)
PHQ-9 spouse
PHQ-9 ()	4.03/3 (0–10)	3.2	0.88	0.4 (0.37–0.51)	22/137 (16.05%)
Major depressive s.	0 (0%)
Other depressive s.	6 (4.38%)
Depressive s. +	16 (11.67%)
Depressive s. −	115 (83.95%)